Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Myelodysplastic syndromes].

K Geissler1

  • 1I. Medizinischen Universitätsklinik Wien.

Wiener Medizinische Wochenschrift (1946)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Myelodysplastic syndromes (MDS) involve stem cell transformation leading to ineffective hematopoiesis and potential acute leukemia. Treatment varies by age, including bone marrow transplant, chemotherapy, supportive care, and growth factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[German Guideline for Idiopathic Pulmonary Fibrosis].

Pneumologie (Stuttgart, Germany)·2020
Same author

Differential regulation of PD-1 and its ligands in allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

[IgE and Anti-IgE in Asthma: A Chequered History].

Pneumologie (Stuttgart, Germany)·2017
Same author

[Not Available].

Laryngo- rhino- otologie·2016
Same author

[Optimal Postoperative Pain Management After Tonsillectomy: An Unsolved Problem].

Laryngo- rhino- otologie·2016
Same author

[Allergic rhinitis in the context of chronic rhinosinusitis].

Laryngo- rhino- otologie·2015
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Stem Cell Biology

Context:

  • Myelodysplastic syndromes (MDS) are neoplastic stem cell disorders.
  • These conditions lead to ineffective hematopoiesis and can evolve into acute leukemia.
  • MDS is characterized by clonal aberrations and altered stem cell patterns.

Purpose:

  • To summarize the pathophysiology of MDS.
  • To outline current treatment strategies for MDS based on patient age and disease characteristics.
  • To highlight the role of bone marrow transplantation, chemotherapy, supportive care, and growth factors.

Summary:

  • MDS results from neoplastic stem cell transformation, causing ineffective blood cell production and risk of acute leukemia.
  • Treatment for younger patients (<50 years) includes HLA-identical donor bone marrow transplantation or aggressive chemotherapy for remission.

Related Experiment Videos

  • Older patients typically receive supportive care, while recombinant hematopoietic growth factors can mitigate cytopenia.

    • Impact:

    • Provides an overview of MDS, a serious stem cell disorder.
    • Clarifies age-dependent treatment approaches for myelodysplastic syndromes.
    • Highlights therapeutic options for improving outcomes in MDS patients.